NL161884C - METHOD FOR DETERMINING CARCINO EMBRYONIC ANTIGENS (CEA) IN A SAMPLE - Google Patents

METHOD FOR DETERMINING CARCINO EMBRYONIC ANTIGENS (CEA) IN A SAMPLE

Info

Publication number
NL161884C
NL161884C NL7314093.A NL7314093A NL161884C NL 161884 C NL161884 C NL 161884C NL 7314093 A NL7314093 A NL 7314093A NL 161884 C NL161884 C NL 161884C
Authority
NL
Netherlands
Prior art keywords
cea
sample
determining
embryonic antigens
carcino embryonic
Prior art date
Application number
NL7314093.A
Other languages
Dutch (nl)
Other versions
NL161884B (en
NL7314093A (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL7314093A publication Critical patent/NL7314093A/xx
Publication of NL161884B publication Critical patent/NL161884B/en
Application granted granted Critical
Publication of NL161884C publication Critical patent/NL161884C/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NL7314093.A 1972-10-13 1973-10-12 METHOD FOR DETERMINING CARCINO EMBRYONIC ANTIGENS (CEA) IN A SAMPLE NL161884C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00297565A US3852415A (en) 1972-10-13 1972-10-13 Compositions for use in radioimmunoassay as a substitute for blood plasma extract in determination of carcinoembryonic antigen

Publications (3)

Publication Number Publication Date
NL7314093A NL7314093A (en) 1974-04-16
NL161884B NL161884B (en) 1979-10-15
NL161884C true NL161884C (en) 1980-03-17

Family

ID=23146844

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7314093.A NL161884C (en) 1972-10-13 1973-10-12 METHOD FOR DETERMINING CARCINO EMBRYONIC ANTIGENS (CEA) IN A SAMPLE

Country Status (15)

Country Link
US (1) US3852415A (en)
JP (1) JPS5315130B2 (en)
AU (1) AU467511B2 (en)
BE (1) BE805991A (en)
CA (1) CA1012458A (en)
CH (1) CH584409A5 (en)
DD (1) DD108151A5 (en)
DE (1) DE2349738C3 (en)
FR (1) FR2203525A5 (en)
GB (1) GB1423244A (en)
IL (1) IL43378A (en)
IT (1) IT1001584B (en)
NL (1) NL161884C (en)
SE (1) SE417460B (en)
ZA (2) ZA723264B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901870A (en) * 1974-03-12 1975-08-26 Behringwerke Ag Derivative of alpha' 1'-fetospecific serum protein and process for its manufacture
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
US4379839A (en) * 1977-05-23 1983-04-12 The Trustees Of Columbia University In The City Of New York Method for detecting cancer
JPS562557A (en) * 1979-06-22 1981-01-12 Green Cross Corp:The Aqueous solvent for coagulation test
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
JPS57208459A (en) * 1981-06-19 1982-12-21 Eisai Co Ltd Measuring method using enzyme-labelled antibody and reagent
US4631254A (en) * 1982-12-06 1986-12-23 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
US4624916A (en) * 1984-04-06 1986-11-25 International Immunoassay Laboratories, Inc. Process and composition for the rapid quantitation of small levels of creative kinase-MB isoenzyme
JPS61280566A (en) * 1984-09-03 1986-12-11 Hiroaki Sawai Direct immunoassay of 2'-5'-oligoadenylic acid
US4690772A (en) * 1985-06-03 1987-09-01 National Medical Care Sterilant compositions
US6022958A (en) * 1986-08-13 2000-02-08 Bayer Corporation cDNAs coding for members of the carcinoembryonic antigen family
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
US5296377A (en) * 1992-12-15 1994-03-22 Boehringer Mannheim Corporation Control reagent containing a hydroxylamine or an antioxidant
AU2011254206B2 (en) 2010-05-20 2015-06-25 Ecolab Usa Inc. Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
KR102384708B1 (en) * 2020-06-19 2022-04-11 대한민국 Artificial blood for bloodstain pattern analysis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3720760A (en) * 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens

Also Published As

Publication number Publication date
SE417460B (en) 1981-03-16
NL161884B (en) 1979-10-15
ZA737693B (en) 1974-08-28
DE2349738B2 (en) 1978-01-19
IL43378A0 (en) 1974-01-14
FR2203525A5 (en) 1974-05-10
JPS5315130B2 (en) 1978-05-23
US3852415A (en) 1974-12-03
AU467511B2 (en) 1975-12-04
CA1012458A (en) 1977-06-21
DE2349738A1 (en) 1974-04-18
ZA723264B (en) 1974-08-28
DE2349738C3 (en) 1981-06-19
NL7314093A (en) 1974-04-16
BE805991A (en) 1974-04-12
DD108151A5 (en) 1974-09-05
GB1423244A (en) 1976-02-04
IL43378A (en) 1976-04-30
JPS4971133A (en) 1974-07-10
IT1001584B (en) 1976-04-30
CH584409A5 (en) 1977-01-31
AU6124273A (en) 1975-05-01

Similar Documents

Publication Publication Date Title
NL161884C (en) METHOD FOR DETERMINING CARCINO EMBRYONIC ANTIGENS (CEA) IN A SAMPLE
NL7801570A (en) METHOD FOR DETERMINING CARCINOEM BRYONIC ANTIGENS.
NL189520C (en) METHOD FOR PREPARING A DETERGENT
NL186657C (en) METHOD FOR DETERMINING ANTIGENS IN A SAMPLE USING ANTI-INSOLUBLE ANTIBODIES.
NL155842B (en) METHOD FOR POLYMERIZING AN ALKES.
NL155597C (en) METHOD FOR PREPARING A DEEP DRAWING SAMPLE AND ARTICLES MADE THEREFROM
NL175691C (en) METHOD FOR PREPARING PREPARATIONS WITH AN INSECT-INSULATING ACTION
NL183896C (en) METHOD FOR PREPARING A CLEANER
NL171496C (en) METHOD FOR ANALYZING CERTAIN SUBSTANCES IN A LIQUID.
NL151366B (en) METHOD FOR PREPARING AN ARALKANOYLAMINOPYRIDINE.
NL7403715A (en) DEVICE FOR DETECTING A DEFECT IN A HEAT-INSULATING SYSTEM.
NL173286C (en) METHOD FOR PREPARING A DISPERSION-HARDENED MATERIAL
NL7413810A (en) DEVICE FOR TAPING A MILK SAMPLE INTO A SAMPLE BARREL.
NL165306C (en) METHOD FOR PREPARING A PARTICULATE, ELECTROSTATOGRAPHIC DEVELOPMENT MATERIAL
NL162132C (en) METHOD FOR PREPARING A DETERGENT
NL167976C (en) METHOD FOR PREPARING A POLYMER
NL7413115A (en) DEVICE FOR DETERMINING THE PROPERTIES OF A SAMPLE OF RADIATION EMITTING PARTICLES SUSPENDED IN A FLUIDUM.
NL7413101A (en) METHOD AND DEVICE FOR OBTAINING SAMPLES.
NL166791C (en) METHOD FOR DETERMINING THE DISTRIBUTION OF A SPECIAL ALLOWANCE
NL189051C (en) METHOD FOR DETERMINING ANTIBODIES IN A SAMPLE
NL171381C (en) METHOD FOR DETECTING IMPERFECTIONS IN A HEAT-INSULATING COATING
NL165295C (en) METHOD FOR INSPECTING A PIPELINE.
NL173766C (en) METHOD FOR PREPARING A LIQUID FUEL
NL177351C (en) PHOTOGRAPHIC MATERIAL FOR CARRYING OUT A DIFFUSION TRANSFER METHOD.
NL163712C (en) METHOD FOR PREPARING INSTANT-READY-DUMMED BOWLS PACKED IN BUCKETS.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: HOFFMANN